HK1211479A1 - Prophylactic or therapeutic drug for constipation - Google Patents

Prophylactic or therapeutic drug for constipation

Info

Publication number
HK1211479A1
HK1211479A1 HK15112295.0A HK15112295A HK1211479A1 HK 1211479 A1 HK1211479 A1 HK 1211479A1 HK 15112295 A HK15112295 A HK 15112295A HK 1211479 A1 HK1211479 A1 HK 1211479A1
Authority
HK
Hong Kong
Prior art keywords
constipation
prophylactic
therapeutic drug
therapeutic
drug
Prior art date
Application number
HK15112295.0A
Other languages
English (en)
Chinese (zh)
Inventor
山本大輔
井尾房代
山本浩二
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of HK1211479A1 publication Critical patent/HK1211479A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15112295.0A 2013-02-04 2015-12-15 Prophylactic or therapeutic drug for constipation HK1211479A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013019754 2013-02-04
PCT/JP2014/052465 WO2014119787A1 (fr) 2013-02-04 2014-02-03 Médicament à visée prophylactique ou thérapeutique pour la constipation

Publications (1)

Publication Number Publication Date
HK1211479A1 true HK1211479A1 (en) 2016-05-27

Family

ID=51262485

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15112295.0A HK1211479A1 (en) 2013-02-04 2015-12-15 Prophylactic or therapeutic drug for constipation

Country Status (18)

Country Link
US (1) US10022389B2 (fr)
EP (1) EP2952206B1 (fr)
JP (1) JP5807767B2 (fr)
KR (1) KR102078433B1 (fr)
CN (1) CN104955481B (fr)
AU (1) AU2014213251B2 (fr)
BR (1) BR112015017541A2 (fr)
CA (1) CA2899834C (fr)
ES (1) ES2694110T3 (fr)
HK (1) HK1211479A1 (fr)
IL (1) IL240192A (fr)
MX (1) MX346453B (fr)
MY (1) MY176162A (fr)
PH (1) PH12015501696B1 (fr)
RU (1) RU2648467C2 (fr)
SG (2) SG10201700267PA (fr)
TW (1) TWI659739B (fr)
WO (1) WO2014119787A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019142774A (ja) * 2016-06-20 2019-08-29 大正製薬株式会社 腸内環境改善剤

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2830424C3 (de) * 1978-07-11 1982-04-15 Bayer Ag, 5090 Leverkusen alpha -Glucosidase-Inhibitoren
US5651988A (en) 1995-08-18 1997-07-29 Xyrofin Oy Combination osmotic and bulk forming laxatives
MXPA05001549A (es) 2002-08-08 2005-05-05 Kissei Pharmaceutical Derivado de pirazol, composicion medicinal que lo contiene, su uso medicinal, e intermediario para su produccion.
JP2004137245A (ja) 2002-08-23 2004-05-13 Kissei Pharmaceut Co Ltd ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
WO2004019958A1 (fr) 2002-08-27 2004-03-11 Kissei Pharmaceutical Co., Ltd. Derives de pyrazole, composition medicinale contenant ces derives et utilisation medicinale de celle-ci
CN1744916A (zh) 2002-12-04 2006-03-08 橘生药品工业株式会社 预防和治疗高血糖所导致的疾病
DE102004028241B4 (de) 2004-06-11 2007-09-13 Sanofi-Aventis Deutschland Gmbh Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
TWI387454B (zh) * 2004-09-02 2013-03-01 Sucampo Ag 治療胃腸道疾病之方法及組成物
EP2076503B1 (fr) * 2006-05-19 2013-07-17 Taisho Pharmaceutical Co., Ltd Composé de c-phényle-glycitol pour le traitement du diabète
BRPI0713058A2 (pt) 2006-06-29 2012-04-10 Taisho Pharmaceutical Co., Ltd. composto de 1-tioglucitol de c-fenila
TW200817424A (en) 2006-08-04 2008-04-16 Daiichi Sankyo Co Ltd Benzylphenyl glucopyranoside derivatives
TWI499414B (zh) 2006-09-29 2015-09-11 Lexicon Pharmaceuticals Inc 鈉與葡萄糖第２型共同運輸體（ｃｏ-ｔｒａｎｓｐｏｒｔｅｒ ２）的抑制物與其應用方法
JPWO2008072726A1 (ja) 2006-12-14 2010-04-02 大正製薬株式会社 １−フェニル １−チオ−ｄ−グルシト−ル誘導体
GB2447067A (en) * 2007-02-20 2008-09-03 Branko R Babic Alteration of osmotic gradients by polyhydroxy compounds
US8399418B2 (en) 2007-12-27 2013-03-19 Kissei Pharmaceutical Co., Ltd. Monosebacate of pyrazole derivative
CN102007138B (zh) 2008-04-16 2014-05-21 橘生药品工业株式会社 吡唑衍生物的半富马酸盐
KR101653853B1 (ko) * 2009-02-23 2016-09-02 다이쇼 세이야꾸 가부시끼가이샤 Ｓｇｌｔ１ 저해제로서의 ４-이소프로필페닐 글루시톨 화합물
JP2013224263A (ja) 2010-08-19 2013-10-31 Taisho Pharmaceutical Co Ltd ４−イソプロピルフェニルグルシトール化合物
JP5532138B2 (ja) 2010-08-20 2014-06-25 大正製薬株式会社 ４−イソプロピル−６−メトキシフェニルグルシトール化合物
JP5656092B2 (ja) 2010-08-20 2015-01-21 大正製薬株式会社 ４−イソプロピルフェニルグルシトール化合物の結晶形及びその製造方法
AR087701A1 (es) * 2011-08-31 2014-04-09 Japan Tobacco Inc Derivados de pirazol con actividad inhibidora de sglt1
CN104284665B (zh) 2012-05-07 2016-11-16 橘生药品工业株式会社 吡唑衍生物及其医药用途
SG11201503923XA (en) * 2012-11-20 2015-06-29 Lexicon Pharmaceuticals Inc Inhibitors of sodium glucose cotransporter 1

Also Published As

Publication number Publication date
US20150374735A1 (en) 2015-12-31
EP2952206A4 (fr) 2016-06-15
TWI659739B (zh) 2019-05-21
US10022389B2 (en) 2018-07-17
AU2014213251A1 (en) 2015-08-27
CN104955481A (zh) 2015-09-30
PH12015501696A1 (en) 2015-10-12
EP2952206B1 (fr) 2018-10-24
MX2015010029A (es) 2015-10-30
CN104955481B (zh) 2017-10-24
CA2899834A1 (fr) 2014-08-07
KR20150112949A (ko) 2015-10-07
TW201517903A (zh) 2015-05-16
KR102078433B1 (ko) 2020-02-17
AU2014213251B2 (en) 2017-07-20
IL240192A (en) 2017-03-30
JP5807767B2 (ja) 2015-11-10
WO2014119787A1 (fr) 2014-08-07
PH12015501696B1 (en) 2015-10-12
BR112015017541A2 (pt) 2017-07-11
MY176162A (en) 2020-07-24
ES2694110T3 (es) 2018-12-18
RU2648467C2 (ru) 2018-03-26
IL240192A0 (en) 2015-09-24
SG11201506047PA (en) 2015-09-29
JPWO2014119787A1 (ja) 2017-01-26
MX346453B (es) 2017-03-17
EP2952206A1 (fr) 2015-12-09
RU2015137671A (ru) 2017-03-10
CA2899834C (fr) 2020-09-01
SG10201700267PA (en) 2017-02-27

Similar Documents

Publication Publication Date Title
HRP20180684T1 (hr) Kombinacija lijekova
ZA201507576B (en) Pharmaceutical combination drug
GB201308440D0 (en) Therapeutic
HK1223833A1 (zh) 藥物劑型
ZA201600027B (en) Pharmaceutical preparation
EP3046556A4 (fr) Polythérapie médicamenteuse
EP2968179A4 (fr) Formes galéniques pharmaceutiques à libération contrôlée
GB201318668D0 (en) Sonosensitive therapeutic
HK1220633A1 (zh) 含有氨基吡唑衍生物的藥物製劑
HK1211479A1 (en) Prophylactic or therapeutic drug for constipation
ZA201506465B (en) Pharmaceutical preparation
GB201320786D0 (en) Medicament
GB201316662D0 (en) Pharmaceutical Combination
GB201305073D0 (en) Therapeutic means

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230131